Other Issues:

AIDScience Perspectives: Reflections on HIV prevention strategies in the United States in 2002 by David R. Holtgrave. [Free full text article] [About AIDScience articles] [See recent AIDScience articles] [dEbates: Submit a response to this article]

The need to understand vaccine demand. Why plans to deliver AIDS vaccines are on agendas today. by Emily Bass, from the IAVI Report. [Free full text article] [About AIDScience articles] [See recent AIDScience articles] [dEbates: Submit a response to this article]

Hot News: HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Data suggests that the receptor-binding sites on gp120 potentially vulnerable to antibodies are protected by a novel type of camouflage: conformational or entropic masking. Nature 420, 678, 12 December 2002 [Read abstract] [Read commentary from CDC HIV/STD/TB Prevention News Update]

Transgene to manufacture vaccine constructs for IAVI. Transgene (Nasdaq: TRGNY) announced that it has entered into a collaborative agreement with the International AIDS Vaccine Initiative (IAVI) to manufacture pre-clinical lots of IAVI's constructs for a novel form of vaccine. [More]

NeuroAIDS: Could HIV-related cognitive impairment be treated? HIV-1 is associated with a neuroAIDS syndrome that includes cognitive impairment. Studies in mice have determined that the viral coat glycoproteins are the predominant cognitive-impairing component of HIV-1, and that gp120 impairs memory by over stimulating pathways that normally sustain memory. AIDS Research and Human Retroviruses 18(16), 1189, 1 November 2002 [More]

ADODB.Connection error '800a0e7a'

Provider cannot be found. It may not be properly installed.

/Issues/Issue041.asp, line 84